Important information

Due to restrictions under applicable securities laws, the information contained herein is not for release, publication or distribution, in whole or in part, in certain jurisdictions.

By choosing a country below, you certify that you are an individual resident and located in the country selected by you above and that you have read and understood this notice.

Please confirm your location:

 

Disclaimer - Important information

The rights issue of BBS-Bioactive Bone Substitutes Plc (”BBS” or the ”Company”) shall be governed by the laws of Finland. No action has been taken, except solely in Finland and Sweden, in order to register the shares or the subscription rights or for the public offering of the shares or subscription rights.

The rights issue does not apply to persons resident in Australia, South-Africa, Hong Kong, Japan, Canada, Singapore, New Zealand or the United States or in any other country where it would be prohibited by local laws or other regulations. The Company’s shares or the subscription rights have not been registered or will not be registered in accordance with the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"), or under the securities laws of any state of the United States and, accordingly, may not be offered or sold, directly or indirectly, in or into the United States (as defined in Regulation S), unless registered under the U.S. Securities Act or pursuant to an exemption from the registration requirements of the U.S. Securities Act and in compliance with any applicable state securities laws of the United States.

Important information - Disclaimer

The rights issue of BBS-Bioactive Bone Substitutes Plc (”BBS” or the ”Company”) shall be governed by the laws of Finland. No action has been taken, except solely in Finland and Sweden, in order to register the shares or the subscription rights or for the public offering of the shares or subscription rights.

The rights issue does not apply to persons resident in Australia, South-Africa, Hong Kong, Japan, Canada, Singapore, New Zealand or the United States or in any other country where it would be prohibited by local laws or other regulations. The Company’s shares or the subscription rights have not been registered or will not be registered in accordance with the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"), or under the securities laws of any state of the United States and, accordingly, may not be offered or sold, directly or indirectly, in or into the United States (as defined in Regulation S), unless registered under the U.S. Securities Act or pursuant to an exemption from the registration requirements of the U.S. Securities Act and in compliance with any applicable state securities laws of the United States.

Neither the documents on this website nor the information contained therein may be delivered to persons in the above-mentioned countries, nor may such documents or information be copied in any way whatsoever. The Company requires that the respective persons inform themselves of the restrictions on distribution and other delivery of such information outside Finland and Sweden as well as restrictions regarding use of such information and observe all such restrictions. Neither the Company nor the Company’s representatives have any kind of legal responsibility for such violations whether or not such restrictions were known to prospective investors. The Company reserves the right to, in its sole discretion reject any type of share subscription that the Company believes would cause the violation or breach of legislation, rule or regulation.
In order to access the information related to the rights issue, you must certify the following:

- I have carefully read and understood the instructions and restrictions described above and I acknowledge that they are applicable to me.

- I am not resident of the United States, Canada, Australia, Japan, Hong Kong, Singapore, New Zealand or South Africa and I am currently not physically present in any of these countries.

- If I am resident of any other country than Finland or Sweden or if I am currently physically present in any country other than in Finland or Sweden, I have obtained the necessary information about the restrictions applicable to the delivery of this information and my participation in the rights issue and I acknowledge that they are applicable to me.

The rights issue of BBS-Bioactive Bone Substitutes Plc